A Trial of the Safety and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia A

"Federal State Budgetary Institution National Medical Research Centre for Hematology of the Ministry of Health of Russian Federation (Department of Clinical Diagnostics for Hematology and Hemostasis Disorders)", Moscow

"Federal State Budgetary Institution National Medical Research Centre for Hematology of the Ministry of Health of Russian Federation (Department of Traumatology and Reconstructive and Restorative Orthopedics for Patients with Hemophilia)", Moscow

Research Center for Hematology MHSD RF, Moscow

"Federal Budgetary Institution Moscow City Clinical Hospital named after S. P. Botkin", Moscow

"State Institution Komi Republican Oncological Dispensary", Syktyvkar

State budgetary healthcare institution Leningrad Regional Clinical Hospital, Gatchina

Russian Research Institute of Hematology and Transfusiology Federal State Institution of Federal Medical and Biological Agency, Saint Petersburg

City Polyclinic №37, Saint Petersburg

Almazov National Medical Research Centre, Saint Petersburg

"Federal State Budgetary Educational Institution of Higher Education Samara State Medical University of the Ministry of Healthcare of the Russian Federation", Samara

"Federal State Budgetary Educational Institution of Higher Education Bashkir State Medical University of the Ministry of Healthcare of the Russian Federation", Ufa

"State Autonomous Institution for Healthcare Chelyabinsk Regional Clinical Hospital", Chelyabinsk

"LLC Medis", Nizhny Novgorod

"Federal State Budgetary Organization of Science Kirov Research Institute of Hematology and Blood Transfusions of Federal Medical Biological agency", Kirov

"State Autonomous Institution for Healthcare of Sverdlovsk region Sverdlovsk Regional Clinical Hospital №1", Yekaterinburg

State Novosibirsk Regional Clinical Hospital, Novosibirsk

Kuzbass Clinical Hospital named after S.V. Belyaev, Kemerovo